Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Effects of pitavastatin on pressure overload-induced heart failure in mice.

Kameda Y, Hasegawa H, Kubota A, Tadokoro H, Kobayashi Y, Komuro I, Takano H.

Circ J. 2012;76(5):1159-68. Epub 2012 Feb 23.

2.

Pitavastatin reduces oxidative stress and attenuates intermittent hypoxia-induced left ventricular remodeling in lean mice.

Inamoto S, Yoshioka T, Yamashita C, Miyamura M, Mori T, Ukimura A, Matsumoto C, Matsumura Y, Kitaura Y, Hayashi T.

Hypertens Res. 2010 Jun;33(6):579-86. doi: 10.1038/hr.2010.36. Epub 2010 Mar 19.

PMID:
20300107
3.

The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.

Higashikuni Y, Sainz J, Nakamura K, Takaoka M, Enomoto S, Iwata H, Tanaka K, Sahara M, Hirata Y, Nagai R, Sata M.

Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):654-61. doi: 10.1161/ATVBAHA.111.240341. Epub 2011 Nov 23.

4.

Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.

Liao Y, Asakura M, Takashima S, Ogai A, Asano Y, Shintani Y, Minamino T, Asanuma H, Sanada S, Kim J, Kitamura S, Tomoike H, Hori M, Kitakaze M.

Circulation. 2004 Aug 10;110(6):692-9. Epub 2004 Jul 19.

5.

Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway.

Saka M, Obata K, Ichihara S, Cheng XW, Kimata H, Noda A, Izawa H, Nagata K, Yokota M.

Clin Exp Pharmacol Physiol. 2006 Dec;33(12):1164-71.

PMID:
17184496
6.

Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.

Yagi S, Akaike M, Aihara K, Ishikawa K, Iwase T, Ikeda Y, Soeki T, Yoshida S, Sumitomo-Ueda Y, Matsumoto T, Sata M.

Hypertension. 2010 Apr;55(4):918-23. doi: 10.1161/HYPERTENSIONAHA.109.146076. Epub 2010 Mar 1.

7.

Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.

Oudit GY, Kassiri Z, Zhou J, Liu QC, Liu PP, Backx PH, Dawood F, Crackower MA, Scholey JW, Penninger JM.

Cardiovasc Res. 2008 Jun 1;78(3):505-14. doi: 10.1093/cvr/cvn041. Epub 2008 Feb 15.

8.

Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.

Li XM, Ma YT, Yang YN, Liu F, Chen BD, Han W, Zhang JF, Gao XM.

Clin Exp Pharmacol Physiol. 2009 Nov;36(11):1054-61. doi: 10.1111/j.1440-1681.2009.05243.x. Epub 2009 Jun 29.

PMID:
19566828
9.

K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.

Gao S, Long CL, Wang RH, Wang H.

Cardiovasc Res. 2009 Aug 1;83(3):444-56. doi: 10.1093/cvr/cvp099. Epub 2009 Mar 20.

10.

Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.

Yagi S, Aihara K, Ikeda Y, Sumitomo Y, Yoshida S, Ise T, Iwase T, Ishikawa K, Azuma H, Akaike M, Matsumoto T.

Circ Res. 2008 Jan 4;102(1):68-76. Epub 2007 Oct 25.

11.

Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction.

Hayashidani S, Tsutsui H, Shiomi T, Suematsu N, Kinugawa S, Ide T, Wen J, Takeshita A.

Circulation. 2002 Feb 19;105(7):868-73.

12.

Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats.

Sakata Y, Masuyama T, Yamamoto K, Nishikawa N, Yamamoto H, Kondo H, Ono K, Otsu K, Kuzuya T, Miwa T, Takeda H, Miyamoto E, Hori M.

Circulation. 2000 Oct 31;102(18):2269-75.

13.

Role of oxidative stress in transition of hypertrophy to heart failure.

Dhalla AK, Hill MF, Singal PK.

J Am Coll Cardiol. 1996 Aug;28(2):506-14.

14.

Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.

Chang SA, Kim YJ, Lee HW, Kim DH, Kim HK, Chang HJ, Sohn DW, Oh BH, Park YB.

Hypertension. 2009 Sep;54(3):591-7. doi: 10.1161/HYPERTENSIONAHA.109.131243. Epub 2009 Jun 29.

15.

Variable phenotype in murine transverse aortic constriction.

Mohammed SF, Storlie JR, Oehler EA, Bowen LA, Korinek J, Lam CS, Simari RD, Burnett JC Jr, Redfield MM.

Cardiovasc Pathol. 2012 May-Jun;21(3):188-98. doi: 10.1016/j.carpath.2011.05.002. Epub 2011 Jul 18.

16.

Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure.

Saka M, Obata K, Ichihara S, Cheng XW, Kimata H, Nishizawa T, Noda A, Izawa H, Nagata K, Murohara T, Yokota M.

J Cardiovasc Pharmacol. 2006 Jun;47(6):770-9.

PMID:
16810078
17.

Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice.

Liao Y, Takashima S, Zhao H, Asano Y, Shintani Y, Minamino T, Kim J, Fujita M, Hori M, Kitakaze M.

Cardiovasc Res. 2006 Apr 1;70(1):107-16. Epub 2006 Feb 28.

18.

EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant.

van Empel VP, Bertrand AT, van Oort RJ, van der Nagel R, Engelen M, van Rijen HV, Doevendans PA, Crijns HJ, Ackerman SL, Sluiter W, De Windt LJ.

J Am Coll Cardiol. 2006 Aug 15;48(4):824-32. Epub 2006 Jul 25.

19.

Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress.

Zhao H, Liao Y, Minamino T, Asano Y, Asakura M, Kim J, Asanuma H, Takashima S, Hori M, Kitakaze M.

Hypertens Res. 2008 Oct;31(10):1977-87. doi: 10.1291/hypres.31.1977.

PMID:
19015605
20.

Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.

Chen HJ, Yao L, Chen TG, Yu M, Wang LH, Chen JZ.

Chin Med J (Engl). 2007 Nov 5;120(21):1902-7.

PMID:
18067764
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk